Redeye: Xvivo is scheduled to release its second-quarter earnings results tomorrow before the stock market opens. Following the release, the company will host a telephone conference at 2:00 p.m. CET. We expect to see a significant impact from the coronavirus outbreak in Q2 although the visibility is low. However, the outlook and comments surrounding the rest of the year are more important than the short-term effects during the second quarter. We continue to argue that Xvivo is well positioned in the medtech sector and that the long-term potential is intact.